Gyre Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
|
|
# Strong Buys
|
|
|
# Buys
|
|
|
# Holds
|
|
|
# Sells
|
|
|
# Strong Sells
|
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-09-30
|
-0.75
|
-1.05
|
-0.30
|
-40.00%
|
|
2023-06-30
|
-0.07
|
-1.05
|
-0.98
|
-1400.00%
|
|
2023-03-31
|
-0.07
|
0.15
|
0.22
|
314.29%
|
|
2022-12-31
|
-0.11
|
-19.05
|
-18.95
|
-18042.86%
|
|
2022-09-30
|
-0.10
|
-2.40
|
-2.30
|
-2300.00%
|
|
2022-06-30
|
-0.25
|
24.60
|
24.85
|
10140.82%
|
|
2022-03-31
|
-0.46
|
-6.90
|
-6.44
|
-1410.84%
|
|
2021-12-31
|
-0.59
|
-9.75
|
-9.16
|
-1559.57%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-1.95
|
|
2022-12-31
|
-3.75
|
|
2021-12-31
|
-43.20
|
|
2020-12-31
|
-42.45
|
|
2019-12-31
|
-70.50
|
|
2018-12-31
|
-39.75
|
|
2017-12-31
|
-27.44
|
|
2016-12-31
|
-165.78
|
|
2015-12-31
|
-512.55
|
|
2014-12-31
|
-0.96
|
|
2013-12-31
|
-958.12
|
|
2012-12-31
|
-330.46
|
|
2011-12-31
|
-378.92
|
|
2010-12-31
|
575.52
|
|
2009-12-31
|
-2340.33
|
|
2008-12-31
|
-1637.62
|
|
2007-12-31
|
-2239.72
|
|
2006-12-31
|
-42.77
|